Effect of 8-week combination therapy with an extended-release α1-blocker (bunazosin or doxazosin) in inadequate responders to an angiotensin ii antagonist (valsartan) in patients with stage 1 or 2 essential hypertension

Yang S.-C.Tsai W.-I.Liau C.-S.TZUNG-DAU WANG2020-12-012020-12-0120131011-6842https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874606705&partnerID=40&md5=b397718f170ca4d0dbad9d2fff6b4119https://scholars.lib.ntu.edu.tw/handle/123456789/523362Effect of 8-week combination therapy with an extended-release α1-blocker (bunazosin or doxazosin) in inadequate responders to an angiotensin ii antagonist (valsartan) in patients with stage 1 or 2 essential hypertensionjournal article2-s2.0-84874606705